Top Pharmaceuticals companies in Netherlands by Gross Profit Margin

This ranking features the top 11 Pharmaceuticals companies in Netherlands ranked by Gross Profit Margin, averaging a Gross Profit Margin of 63.05%, for January 15, 2025.

Netherlands

Pharmaceuticals
Gross Profit Margin
#
Name
Gross Profit Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
NAMS

NewAmsterdam Pharma Company N.V.

1

NAMS
100.00%
Dec. 31, 2023 USD 23.67 -3.70%

Netherlands
2
MRUS

Merus N.V.

2

MRUS
100.00%
Dec. 31, 2023 USD 39.01 -3.56%

Netherlands
3
PRQR

ProQR Therapeutics N.V.

3

PRQR
97.95%
Dec. 31, 2023 USD 2.26 -0.44%

Netherlands
4
ARGX.BR

argenx SE

4

ARGX.BR
90.39%
Dec. 31, 2023 USD 673.61 1.66%

Netherlands
5
PHAR

Pharming Group N.V.

5

PHAR
89.72%
Dec. 31, 2023 USD 9.93 5.98%

Netherlands
6
QGEN

Qiagen N.V.

6

QGEN
62.23%
Dec. 31, 2023 USD 45.57 -0.94%

Netherlands
7
LVTX

LAVA Therapeutics N.V.

7

LVTX
48.56%
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands
8
PHIA.AS

Koninklijke Philips N.V.

8

PHIA.AS
40.99%
Dec. 31, 2023 USD 24.98 -2.69%

Netherlands
9
IMCD.AS

IMCD N.V.

9

IMCD.AS
25.27%
Dec. 31, 2023 USD 139.49 1.47%

Netherlands
10
RDC.DE

Redcare Pharmacy NV

10

RDC.DE
24.48%
Dec. 31, 2023 USD 121.51 5.06%

Netherlands
11
QURE

uniQure N.V.

11

QURE
13.98%
Dec. 31, 2023 USD 13.23 -4.06%

Netherlands
Frequently Asked Questions
  • Which Pharmaceuticals company in Netherlands has the highest Gross Profit Margin ?

    The Pharmaceuticals company in Netherlands with the highest Gross Profit Margin is NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) at 100.00%.

  • Which Pharmaceuticals company in Netherlands has the lowest Gross Profit Margin ?

    The Pharmaceuticals company in Netherlands with the lowest Gross Profit Margin is uniQure N.V. (NasdaqGS: QURE) at 13.98%.